Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Announces Feed Conference Attendance in Bangkok, Thailand April 8 to 10

TheNewsWire April 7, 2014

Avivagen Announces Voting Results for the Election of its Directors

TheNewsWire April 4, 2014

Avivagen Announces Poultry Trial Agreement with Chonbuk National University of Korea

TheNewsWire March 31, 2014

Avivagen Announces Swine Trial Agreement with National Institute of Animal Sciences for Vietnam

TheNewsWire March 25, 2014

Avivagen (V.VIV) CEO update: Harder push into livestock products, licensing new IP

Canadian Press March 17, 2014

Avivagen Announces CEO Update Letter

TheNewsWire March 17, 2014

Avivagen (V.VIV) adds Prometic Life Sciences (T.PLI) Chairman Kym Anthony to the board

Chris Parry February 28, 2014

Avivagen Announces Nomination of New Director Mr. G.F. Kym Anthony Standing for Election

TheNewsWire February 28, 2014

Avivagen Announces Stock Option Pool Increase

TheNewsWire February 14, 2014

Avivagen (V.VIV) Ox-C beta tech study peer-reviewed in Canadian Journal of Chemistry

Chris Parry February 5, 2014

Avivagen Announces Peer-Reviewed Journal Publication

TheNewsWire February 5, 2014

Avivagen (V.VIV) shares on the move: 16.6% jump in anticipation of news

Chris Parry February 4, 2014

Avivagen (V.VIV) makes push into Asian livestock feed market, stock up 16%

Chris Parry December 12, 2013

Avivagen Announces CEO Update Letter

TheNewsWire December 12, 2013

Avivagen Announces Correction to Private Placement Disclosure

TheNewsWire November 20, 2013

Avivagen Announces Second Closing of Private Placement

TheNewsWire November 14, 2013

Avivagen Closes Private Placement

TheNewsWire October 3, 2013

Avivagen Attending New England Pet Expo

TheNewsWire September 18, 2013

Avivagen Announces Proposed Private Placement

TheNewsWire August 23, 2013

Avivagen Announces U.S. Product Launch of Vivamune for Cats

TheNewsWire August 20, 2013